Implications of the population structure of the Mycobacterium tuberculosis complex in Benin for tuberculosis presentation, diagnosis and outcome
Consequences of Mycobacterium tuberculosis genetic diversity in the context of HIV co-infection for laboratory diagnosis of tuberculosis in Africa
Ontwikkeling van nieuwe methoden voor het voorspellen van het drug resistentie fenotype van Mycobacterium tuberculosis varianten.
"Hit-to-lead" en "lead" optimialisatie voor gerichte behandeling van infecties met Mycobacterium tuberculosis.
The predominance of Ethiopian specific Mycobacterium tuberculosis families and minimal contribution of Mycobacterium bovis in tuberculous lymphadenitis patients in Southwest Ethiopia
Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital
Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis
Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali
Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients
A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant